"Saudi Arabia Pharmaceuticals & Healthcare Report Q1 2014" Now Available at Fast Market Research
Despite some issues over its intellectual property (IP) regime, Saudi Arabia will continue to present a considerable longer-term opportunity for pharmaceutical companies. The Kingdom - which is the richest and largest of the Gulf states - has a large and growing population that is heavily afflicted by conditions related to sedentary lifestyles. Though imports will continue to meet most of the demand for pharmaceuticals, we also envisage a steady stream of government investment in drug manufacturing.
View full press release